However, with any injection-based treatment, there is a risk of redness, swelling, bruising, and injection at the injection site
Side Effects and Safety Reported Side Effects (Rare) Mild headache (transient, first dose) Slight injection site irritation Nausea (if dosed too high on empty stomach) Sleep quality changes (usually improvement) Safety Profile Non-hormonal doesn't suppress testosterone or disrupt hormonal systems No major contraindications known No overdose risk excess peptide is simply cleared Well-tolerated across diverse populations No organ toxicity safe for liver, kidney, heart Contraindications (Caution) Active cancer growth-promoting effects could theoretically benefit cancer (no direct evidence, but be cautious) Pregnancy insufficient human data Active infection at injection site standard sterile injection protocols apply Drug Interactions No known major interactions with common medications
However, techniques such as transaxillary or transumbilical placement avoid scars on the breast itself
Graphical Abstract Similar content being viewed by others Introduction Premature ovarian insufficiency (POI), whether idiopathic or resulting from chemotherapy-induced ovarian failure (CIOF), poses a significant threat to the reproductive and endocrine health of women globally [1, 2]
S., Tomarken, A